No Detail Found!

Clarithromycin loaded lipid polymer hybrid nanoparticles: fabrication, in vitro and in vivo evaluation

Author(s)
Muhammad Asghar Khan Department of Pharmacy, University of Malakand,Chakdara, Dir (L), Khyber Pakhtunkhwa,Pakistan
Shahzeb Khan Department of Pharmacy, University of Malakand, Chakdara, Dir (L), Khyber Pakhtunkhwa, Pakistan; Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, USA
Muhammad Shahid Department of Pharmacy, Sarhad University Peshawar KPK,,Pakistan
Abida Raza Nanotheranostics Research Group, National Institute of Laser and Optronics (NILOP), Islamabad-7469, Pakistan
Zahid Hussain Department of Pharmaceutics & Pharmaceutical Technology, College of Pharmacy,University of Sharjah,Sharjah, UAE,
Muhammad Sohail Department of Pharmacy, COMSATS University,Islamabad,Pakistan
Muhammad Usman minhas College of Phamracy, University of Sargodha,Sargodha,Pakistan
Syed Wadood Ali Shah Department of Pharmacy, University of Malakand,Chakdara, Dir (L), Khyber Pakhtunkhwa,Pakistan
Noshed Khan Department of Cardiology, Lady Reading Hospital,Peshawar, KPK,Pakistan
Jahangir Khan Department of Pharmacy, University of Malakand,Chakdara, Dir (L), Khyber Pakhtunkhwa,Pakistan
Zakirullah Khan District headquarter Hospital, Lakki Marwat, KPK, Pakistan
Heather C Aziz Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas, Austin, Texas, USA
Abstract
Clarithromycin; a Macrolide antibiotic is used to treat various bacterial infections. Unluckily, its hydrophobic nature adds to its variable and pitiable oral bioavailability. In the current study, clarithromycin loaded Lipid Polymer Hybrid Nanoparticles (LPHNs) were produced followed by in vitro and in vivo evaluation. Clarithromycin loaded LPHNs (CHNF-5) with particle size 125.31±2.5nm and PDI (0.312±0.01) showed high entrapment efficiency 96%, and drug loading capacity 0.596 % ± 0.014. Spherical shaped particles were confirmed by scanning electronic microscopy. Differential Scanning Calorimetry and Powder X-Ray Diffraction confirmed the crystalline properties of the LPHNs. The engineered nanoparticles exhibited high stability at different temperature. Dissolution studies demonstrated that LPHNs effectively sustained the drug release rate. In vivo pharmacokinetic studies of the produced LPHNs demonstrated significant increase in the maximum peak plasma concentration (1390 ng/mL, P<0.001), AUC (14146 ng h/mL, P<0.001), and eradication half-life (11.6 h, P<0.01)
Publication Details
Page(s) 1303-1313
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: SUP3, Year: 2020

Request the full text from PASTIC

Keywords
dissolution, Bioavailability, stability, Clarithromycin, Lipid polymer hybrid nanoparticle
References
Ahmed S,Govender T,Khan I,ur Rehman N,Ali W,Shah SMH,Khan S,Hussain Z,Ullah R,Alsaid MS .2018 .Experimental and molecular modeling approach to optimize suitable polymers for fabrication of stable fluticasone nanoparticles with enhanced dissolution and antimicrobial activity. Drug Des. Devel. Ther., 12 : 255-269.
Awadallah H,Awidat S,El-Mahmoudy A .2016 .Pharmacokinetics of clarithromycin after single intravenous and intracrop bolus administrations to broiler chickens. Int. J. Pharmacol. Toxicol., 4(1) : 12-18.
Barzegar-Jalali M .2008 .Kinetic analysis of drug release from nanoparticles. JPPS, 11(1) : 167-177.
Bhardwaj U,Burgess DJ U .2010 .A novel USP apparatus 4 based release testing method for dispersed systems. Int. J. Pharm., 388(1-2) : 287-294.
Lobo Costa P,JMS Costa P .2001 .Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci., 13(2) : 123-133.
Dehaini D,Fang RH,Luk BT,Pang Z,Hu C-MJ,Kroll AV,Yu CL,Gao W .2016 .Ultra-small lipid-polymer hybrid nanoparticles for tumorpenetrating drug delivery. Nanoscale, 8(30) : 14411-14419.
Gao W,Chen Y,Zhang Y,Zhang Q,Zhang L Q .2018 .Nanoparticle-based local antimicrobial drug delivery. Adv. Drug Deliv. Rev., 127 : 46-57.
Garg NK,Singh B,Sharma G,Kushwah V,Tyagi RK,Jain S,Katare OP .2015 .Development and characterization of single step self-assembled lipid polymer hybrid nanoparticles for effective delivery of methotrexate. RSC Advances, 5(77) : 62989-62999.
Ghanshyam U,Patel P,Patel J .2011 .Formulation and characterization of solid lipid nanoparticles dry powder inhaler containing triamcinolone acetonide. IJRPC, 1(3) : 662-673.
Hameed HA,Khan S,Shahid M,Ullah R,Bari A,Ali SS,Hussain Z,Sohail M,Khan SU,Htar TT .2020 .Engineering of Naproxen Loaded Polymer Hybrid Enteric Microspheres for Modified Release Tablets: Development, Characterization, in silico Modelling and in vivo Evaluation. Drug Des. , 14 : 27-41.
Ishiguro N,Koseki N,Kaiho M,Ariga T,Kikuta H,Togashi T,Oba K,Morita K,Nagano N,Nakanishi M .2017 .Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. PloS One, 12(3) : 1-13.
Kamaly N,Yameen B,Wu J,Farokhzad OC .2016 .Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem, 116(4) : 2602-2663.
Khan S,Matas Md,Anwar Zhang J,J Zhang J .2013 .Nanocrystal preparation: low-energy precipitation method revisited. Crystal Growth & Design, 13(7) : 2766-2777.
Lee BK,Yun YH,Park K YH .2015 .Smart nanoparticles for drug delivery: Boundaries and opportunities. Chem, 125 : 158-164.
Lestari ML,Müller RH,Möschwitzer JP .2015 .Systematic screening of different surface modifiers for the production of physically stable nanosuspensions. J. Pharm. Sci., 104(3) : 1128-1140.
Liu Y,Pan J,Feng S-S .2010 .Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: Effects of surfactants on particles size, characteristics and in vitro performance. Int. J. Pharm., 395(1-2) : 243-250.
Maji R,Omolo CA,Agrawal N,Maduray K,Hassan D,Mokhtar C,Mackhraj I,Govender T .2019 .pHresponsive lipid-dendrimer hybrid nanoparticles: An approach to target and eliminate intracellular pathogens. Mol. Pharm, 16(11) : 4594-4609.
Mishra R,Gautam S,Prasad RK,Patel A,Sahu A .2016 .Solubility enhancement of clarithromycin using solid dispersion and effervescence assisted fusion technique. RJPT, 9(6) : 677-686.
Moffat AC,Osselton MD,Widdop B,Clarke E,Fluids Body,Materials Postmortem,Pharmaceutical Press .2004 .Clarke's analysis of drugs and poisons. , 1 : .
Mohammadi G,Nokhodchi A,Barzegar-Jalali M,Lotfipour F,Adibkia K,Ehyaei N,Valizadeh H N .2011 .Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system. Colloids Surf. B, 88(1) : 39-44.
Niu Z,Conejos-Sánchez I,Griffin BT,O'Driscoll CM,Alonso MJ CM .2016 .Lipid-based nanocarriers for oral peptide delivery. Adv. Drug Deliv. Rev., 106 (Part B, : 337-354.
Peng L,Liu S,Feng A,Yuan J .2017 .Polymeric nanocarriers based on cyclodextrins for drug delivery: host-guest interaction as stimuli responsive linker. Mol. Pharm, 14(8) : 2475-2486.
Rahim H,Sadiq A,Khan S,Khan MA,Shah SMH,Hussain Z,Ullah R,Shahat AA,Ibrahim K AA .2017 .Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies. Drug Des. Devel. Ther., 11 : 2443-2452.
Rajbhar P,Sahu AK,Gautam S,Prasad RK,Singh V,Nair S V,Part A .2016 .Formulation and evaluation of clarithromycin co-crystals tablets dosage forms to enhance the bioavailability. TPI Journal, 5(6) : 05-13.
Sadiq AA,Abdul Rassol A .2014 .Formulation and evaluation of silibinin loaded solid lipid nanoparticles for peroral use targeting lower part of gastrointestinal tract. Int. J. Pharm. Pharm. Sci., 6(1) : 55-67.
Seedat N,Kalhapure RS,Mocktar C,Vepuri S,Jadhav M,Soliman M,Govender T .2016 .Co-encapsulation of multi-lipids and polymers enhances the performance of vancomycin in lipid-polymer hybrid nanoparticles: In vitro and in silico studies. Mater. Sci. Eng, 61 : 616-630.
Shah SMH,Ullah F,Khan S,Shah SMM,De Matas M,Hussain Z,Minhas MU,AbdEl-Salam NM,Assi KH,Isreb M .2016 .Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation. Drug Des. Devel. Ther., 10 : 3837-3850.
Sharma M,Gupta N,Gupta S N .2016 .Implications of designing clarithromycin loaded solid lipid nanoparticles on their pharmacokinetics, antibacterial activity and safety. RSC Advances, 6(80) : 76621-76631.
Tacconelli E,Carrara E,Savoldi A,Harbarth S,Mendelson M,Monnet DL,Pulcini C,Kahlmeter G,Kluytmans J,Carmeli Y .2018 .development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis., 18(3) : 318-327.
Tiţa B,Fuliaş A,Bandur G,Marian E,Tiţa D .2011 .Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms. J. Pharm. Biomed., 56(2) : 221-227.
Ullah N,Khan S,Ahmed S,Govender T,Faidah HS,de Matas M,Shahid M,Minhas MU,Sohail M,Khurram M M .2018 .Dexibuprofen nanocrystals with improved therapeutic performance: Fabrication, characterization, in silico modeling, and in vivo evaluation. Int. J. Nanomed., 13 : 1677-1692.
Uprit S,Sahu RK,Roy A,Pare A .2013 .Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm. J., 21(4) : 379-385.
Uskokovic V .2015 .Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis. Crit. Rev. Ther. Drug Carrier Syst., 32(1) : 1-59.
Wang L,Hu C,Shao L C .2017 .The antimicrobial activity of nanoparticles: Present situation and prospects for the future. Int. J. Nanomed., 12 : 1227-1249.
Wang Y,Zheng Y,Zhang L,Wang Q,Zhang D Q .2013 .Stability of nanosuspensions in drug delivery. J. Control. Release, 172(3) : 1126-1141.
0

Citations

0

Downloads

14

Views